TerminatedNo phase
Functional Assessment in Liver Transplantation
Key facts
- Who runs it
- Baylor Research Institute
- Where
- Dallas, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 411 people enrolled
- Started
- 6 Oct 2015
- Ended
- 8 May 2024
- Type of study
- Observational
- Record updated
- 27 January 2026
- Why it stopped
- study transitioned from LIRB to CIRB
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Adults (≥18 years old)
- Listed for liver transplantation, or are "listable" - i.e, have undergone formal evaluation and been approved for listing if/when patients achieve high enough priority
- Are seen in the outpatient clinic setting
Who cannot take part
- Have severe hepatic encephalopathy at enrollment (defined by the time to complete the Numbers Connection Test (NCT) > 120 seconds, which is the first test that the participants complete upon enrollment)
Where in United States
- Baylor University Medical CenterDallas, United StatesNo longer taking part
About the trial
What the trial wants to find out
In order to ensure the equity of the liver allocation process, it is important to create objective, scientifically validated markers of frailty in patients with end-stage liver disease that accurately predict patient outcomes. Many measures have been developed to assess this clinical state in elderly patients, but none have been applied to patients with cirrhosis, a population at increased risk for accelerated functional decline. This protocol is designed to learn more about the effects of functional status (also known as "frailty") in liver transplant patients and patient outcomes both before and after liver transplant.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 27 January 2026